• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Bristol Myers gets key FDA approval for bone marrow disease drug

cafead

Administrator
Staff member
  • cafead   Aug 30, 2023 at 10:12: AM
via The expanded OK for Reblozyl in myelodysplastic syndromes could help the company offset looming patent cliffs for some of its top-selling medicines.

article source